Asprin And Extended-Release Dipyridamole
Product manufactured by Glenmark Pharmaceuticals Inc., Usa
Indications and Purposes
| 1 Indications And Usage Aspirin And Extended-Release Dipyridamole Capsules Are Indicated To Reduce The Risk Of Stroke In Patients Who Have Had Transient Ischemia Of The Brain Or Completed Ischemic Stroke Due To Thrombosis. • Aspirin And Extended-Release Dipyridamole Capsules Are A Combination Antiplatelet Agent Indicated To Reduce The Risk Of Stroke In Patients Who Have Had Transient Ischemia Of The Brain Or Completed Ischemic Stroke Due To Thrombosis ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Aspirin |
|
ZINC53 |
| 2. Dipyridamole |
|
ZINC643046 |